Teplizumab
-
{
- All
- News
'Teplizumab' - 1 News Result(s)
-
New Drug Delays Type 1 Diabetes By Up To 3 Years, UK Health Body Approves
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it works on the underlying cause of Type 1 diabetes. The medicine helps stop the immune system from attacking the insulin-producing beta cells in the pancreas.
'Teplizumab' - 1 News Result(s)
-
New Drug Delays Type 1 Diabetes By Up To 3 Years, UK Health Body Approves
Teplizumab is an immunotherapy drug designed to modify the immune system's response. Instead of simply treating symptoms, it works on the underlying cause of Type 1 diabetes. The medicine helps stop the immune system from attacking the insulin-producing beta cells in the pancreas.
